BioInformant@StemCellMarket

Cade Hildreth, Founder: As the 1ST and ONLY market research firm to specialize in the #stemcell industry, BioInformant has been cited by WSJ, Xconomy, & Vogue.

 Washington, DC
bioinformant.com
Joined July 2014
1,904 Photos and videos
Aspen Neuroscience Advances Sasineprocel, an Autologous iPSC-Based Therapy for Parkinson’s Disease, Toward Phase 3 - bioinformant.com/aspen-neuro… @AspenNeuro
123
Anja Health Makes Cord Blood, Cord Tissue and Placenta Banking an Employee Benefit and Invites Other Employers to Join In - bioinformant.com/anja-health… @anjahealth @vitalant
1
1
175
Cord Blood Industry Consolidation Escalates in 2026 - bioinformant.com/cord-blood-… @cordblood @cryobank @GenerateLifeSci @NateraGenetics @ViaCord @PerkinElmer @humanlongevity @Lifebankusa @bmsnews @CryoCell @bcumexico @dentcell @cryocord @PBKM_FamiCord @celularity @AlphaCord
1
257
MUSE Cells Now Available at Longevity Medical Institute® - bioinformant.com/muse-cells-… As part of its Regenerative Neurology Program, @Longevity_Cabo is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotech laboratory.
302
Five Acquisitions, $600M in VC, and a $1B Milestone: Exosome Dealmaking in 2026 - bioinformant.com/exosome-dea… @mdxhealth @NexTelMedical @exocobio
2
254
Cryopraxis, BioNK and Radboudumc Partner to Transfer Cord Blood-Derived NK Cell Technology to Brazil - bioinformant.com/cryopraxis-… @cryopraxis @radboudumc
218
Greenstone Biosciences Wins Breakthrough T1D Grant to Model Diabetes Using Patient-Derived iPSCs - bioinformant.com/greenstone-… @GreenstoneBio @BreakthroughT1D

Greenstone Biosciences Wins Breakthrough T1D Grant to Model Diabetes Using Patient-Derived iPSCs |...

Greenstone Biosciences Awarded Breakthrough T1D Grant to Advance Islet Cell Platform PALO ALTO, Calif. –Greenstone Biosciences has been awarded a Breakthrough T1D Industry Discovery and Development...

bioinformant.com
202
New Book “The Language of Healing” Tackles the Patient Education Gap in Regenerative Medicine - bioinformant.com/new-book-th… @Longevity_Cabo

New Book "The Language of Healing" Tackles the Patient Education Gap in Regenerative Medicine |...

The regenerative medicine industry has a communication problem, and it isn’t a scientific one. The field now broadly accepts that mesenchymal stem/stromal cells (MSCs) exert their effects largely...

bioinformant.com
2
2
198
IPS HEART’s iPSC-Derived Cell Therapy, ISX9-CPC, Secures 8th FDA Regulatory Milestone - bioinformant.com/ips-heart-s…
2
1
399
Cell Therapy CDMO Cellipont Bioservices Celebrates Major Manufacturing Milestone: Releases 100th GMP Batch - bioinformant.com/cellipont-b… @cellipont
307
Aspen Neuroscience Receives FDA RMAT for Sasineprocel (ANPD001), an Autologous iPSC-Based Therapy for PD - bioinformant.com/aspen-neuro… @AspenNeuro
281
Top Companies Developing Cell Therapy Treatments For Diabetes in 2026 - bioinformant.com/stem-cells-… @Sernovabio @NextCellPharma @Mesoblast @Evotec @OrgenesisInc @novonordisk @beta_o2 @EliLillyandCo @PharmaCyte @VertexPharma @aspectbiosys @newcelXltd
305
The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - bioinformant.com/ipsc-derive… @Allele_Biotech @AspenNeuro @averythera @Bayer @BBeigene @BlueRockTx @cartherics @cellectis @CitiusPharma @CladeTx @creativebiolabs @CMTH_Inc @cynatastemcells @CytomedSG @CytoviaTX @Edigene_Inc
1
1
619
China’s First Approved MSC Therapy, Ruibosheng, Hits the Market at a Fraction of Global Pricing - bioinformant.com/chinas-firs…
2
5
493
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel - bioinformant.com/kyverna-the… @KyvernaTx @elevatebio
263
Longevity Medical Institute® Launches Advanced Intranasal Regenerative Neurological Therapy Platform - bioinformant.com/longevity-m… Nose-to-brain delivery system expands options for patients with neurological disorders as an alternative to intrathecal administration. @Longevity_Cabo
2
2
179
🧬The iPSC field hit its 20th anniversary & the data has never looked stronger. The 6th iPSC Drug Development Summit is the only meeting dedicated to advancing iPSC-based cell therapies end-to-end, from discovery through regulatory strategy. ter.li/mvj4x7ya @HansonWade
1
131
MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Knee Osteoarthritis - bioinformant.com/medipost-in… @medipost_en
110
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance - bioinformant.com/porton-adva… @PortonAdvanced @US_FDA
142
Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation - bioinformant.com/syntax-bio-… @ASCAppliedStem @SyntaxBio
105
Load more